---
figid: PMC6415318__BMRI2019-4805926.007
figlink: /pmc/articles/PMC6415318/figure/fig7/
number: F7
caption: Schematic diagram of molecular mechanisms of Shuangyu Tiaozhi Granule (STG)
  attenuates hypercholesterolemia in rat fed HC diet. STG reduces contents of plasma
  cholesterol through the inhibition of cholesterol synthesis pathway and promotion
  of hepatic cholesterol uptake. STG treatment downregulated HMGCR and SREBP-2 expression
  and increased LDLR levels, whereas circulating LDL-C was uptake from plasma. HMGCR,
  3-hydrox-3-methylglutaryl-CoA reductase; LDLR, low-density lipoprotein receptor;
  SREBP-2, sterol regulatory element-binding protein-2; ACAT-2, acyl coenzyme A-cholesterol
  acyltransferase-2; CYP7A1, cholesterol 7-α-hydroxylase; ABCG5, ATP-binding cassette
  transporter G5; ABCG8, ATP-binding cassette transporter G8; (+) promotion, (-) inhibition,
  ↑ represents upregulation, ↓ represents downregulation.
pmcid: PMC6415318
papertitle: Shuangyu Tiaozhi Granule Attenuates Hypercholesterolemia through the Reduction
  of Cholesterol Synthesis in Rat Fed a High Cholesterol Diet.
reftext: Jingjing Shi, et al. Biomed Res Int. 2019;2019:4805926.
pmc_ranked_result_index: '19470'
pathway_score: 0.8652278
filename: BMRI2019-4805926.007.jpg
figtitle: Schematic diagram of molecular mechanisms of Shuangyu Tiaozhi Granule (STG)
  attenuates hypercholesterolemia in rat fed HC diet
year: '2019'
organisms:
- Mus musculus
- Rattus norvegicus
- herbal medicine
- Dioscorea dumetorum
- Ulva prolifera
- Armoracia rusticana
- Dioscorea spongiosa
- Panax ginseng
- Dioscorea japonica
- Trigonella foenum-graecum
- Dioscorea polygonoides
- Homo sapiens
- Oryctolagus cuniculus
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6415318__BMRI2019-4805926.007.html
  '@type': Dataset
  description: Schematic diagram of molecular mechanisms of Shuangyu Tiaozhi Granule
    (STG) attenuates hypercholesterolemia in rat fed HC diet. STG reduces contents
    of plasma cholesterol through the inhibition of cholesterol synthesis pathway
    and promotion of hepatic cholesterol uptake. STG treatment downregulated HMGCR
    and SREBP-2 expression and increased LDLR levels, whereas circulating LDL-C was
    uptake from plasma. HMGCR, 3-hydrox-3-methylglutaryl-CoA reductase; LDLR, low-density
    lipoprotein receptor; SREBP-2, sterol regulatory element-binding protein-2; ACAT-2,
    acyl coenzyme A-cholesterol acyltransferase-2; CYP7A1, cholesterol 7-α-hydroxylase;
    ABCG5, ATP-binding cassette transporter G5; ABCG8, ATP-binding cassette transporter
    G8; (+) promotion, (-) inhibition, ↑ represents upregulation, ↓ represents downregulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SREBF2
  - ABCG8
  - ACAT2
  - LDLR
  - ABCG5
  - C6orf15
  - HMGCR
  - CYP7A1
  - cholesterol
  - cholesterol ester
  - bile acids
genes:
- word: SREBP-2-+)
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: ABCG8
  symbol: ABCG8
  source: hgnc_symbol
  hgnc_symbol: ABCG8
  entrez: '64241'
- word: ACAT-2
  symbol: ACAT2
  source: hgnc_symbol
  hgnc_symbol: ACAT2
  entrez: '39'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: ABCG5
  symbol: ABCG5
  source: hgnc_symbol
  hgnc_symbol: ABCG5
  entrez: '64240'
- word: (STG)
  symbol: STG
  source: hgnc_alias_symbol
  hgnc_symbol: C6orf15
  entrez: '29113'
- word: HMGCR
  symbol: HMGCR
  source: hgnc_symbol
  hgnc_symbol: HMGCR
  entrez: '3156'
- word: CYP7A1
  symbol: CYP7A1
  source: hgnc_symbol
  hgnc_symbol: CYP7A1
  entrez: '1581'
chemicals:
- word: cholesterol
  source: MESH
  identifier: D002784
- word: cholesterol ester
  source: MESH
  identifier: D002788
- word: bile acids
  source: MESH
  identifier: D001647
diseases: []
figid_alias: PMC6415318__F7
redirect_from: /figures/PMC6415318__F7
figtype: Figure
---
